• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无三核苷酸重复序列扩增的强直性肌营养不良症

Myotonic dystrophy with no trinucleotide repeat expansion.

作者信息

Thornton C A, Griggs R C, Moxley R T

机构信息

Neuromuscular Disease Center, University of Rochester School of Medicine and Dentistry, NY 14620.

出版信息

Ann Neurol. 1994 Mar;35(3):269-72. doi: 10.1002/ana.410350305.

DOI:10.1002/ana.410350305
PMID:8122879
Abstract

We report 3 patients from 2 families with myotonic dystrophy who do not show an abnormal expansion of CTG trinucleotide repeats within the myotonic dystrophy gene. Characteristic features of myotonic dystrophy in these patients were frontal balding, cataracts, cardiac conduction abnormalities, and testicular atrophy with myotonia and muscle weakness. Results of muscle histopathology were consistent with myotonic dystrophy. Genetic analysis of leukocyte and muscle DNA showed a normal number of CTG repeats. The demonstration of normal CTG repeat number for the myotonic dystrophy gene does not exclude the diagnosis of myotonic dystrophy.

摘要

我们报告了来自2个家族的3例强直性肌营养不良患者,他们的强直性肌营养不良基因内CTG三核苷酸重复序列未出现异常扩增。这些患者强直性肌营养不良的特征性表现为前额秃发、白内障、心脏传导异常以及伴有肌强直和肌肉无力的睾丸萎缩。肌肉组织病理学结果与强直性肌营养不良一致。白细胞和肌肉DNA的基因分析显示CTG重复序列数量正常。强直性肌营养不良基因CTG重复序列数量正常并不能排除强直性肌营养不良的诊断。

相似文献

1
Myotonic dystrophy with no trinucleotide repeat expansion.无三核苷酸重复序列扩增的强直性肌营养不良症
Ann Neurol. 1994 Mar;35(3):269-72. doi: 10.1002/ana.410350305.
2
Myotonic dystrophy patients have larger CTG expansions in skeletal muscle than in leukocytes.强直性肌营养不良患者骨骼肌中的CTG重复序列扩增比白细胞中的更大。
Ann Neurol. 1994 Jan;35(1):104-7. doi: 10.1002/ana.410350116.
3
[DNA diagnosis in myotonic dystrophy].[强直性肌营养不良症的DNA诊断]
Hokkaido Igaku Zasshi. 1996 Jan;71(1):3-8.
4
Myotonic dystrophy gene analysis in affected Israeli families.对受影响的以色列家庭进行强直性肌营养不良基因分析。
Isr J Med Sci. 1994 Aug;30(8):622-5.
5
[Effects of CTG repeat expansion on quantitative muscle histopathology in myotonic dystrophy].[CTG重复序列扩增对强直性肌营养不良症定量肌肉组织病理学的影响]
Nihon Rinsho. 1997 Dec;55(12):3214-8.
6
[Correlation between degrees of the CTG repeat expansion and clinical features of myotonic dystrophy].[CTG重复序列扩增程度与强直性肌营养不良临床特征的相关性]
Rinsho Shinkeigaku. 1994 Feb;34(2):118-23.
7
[A case of myotonic dystrophy showing proximal dominant muscle involvement but not myotonia].1例强直性肌营养不良症表现为近端肌肉为主受累但无肌强直
Rinsho Shinkeigaku. 1999 Apr;39(4):461-4.
8
Prenatal diagnosis of congenital myotonic dystrophy and counseling of the pregnant mother: case report and literature review.先天性肌强直性营养不良的产前诊断及对孕妇的咨询:病例报告与文献综述
Am J Med Genet. 1998 Jul 7;78(3):250-3.
9
Clinical characteristics of myotonic dystrophy type 1 patients with small CTG expansions.1型强直性肌营养不良症患者小CTG重复扩增的临床特征
Neurology. 2006 Apr 25;66(8):1248-50. doi: 10.1212/01.wnl.0000208513.48550.08.
10
[The relationship between muscle pathology and DM kinase abnormalities in patients with dystrophia myotonica].[强直性肌营养不良患者肌肉病理学与DM激酶异常之间的关系]
Rinsho Shinkeigaku. 1996 Sep;36(9):1055-9.

引用本文的文献

1
Investigating phenotypic variability patterns in myotonic dystrophy type 2 in a neuromuscular referral center retrospective cohort.在一家神经肌肉转诊中心的回顾性队列中研究2型强直性肌营养不良的表型变异性模式。
Neuromuscul Disord. 2025 Feb;47:105255. doi: 10.1016/j.nmd.2024.105255. Epub 2024 Nov 26.
2
Updated Structure of Repeat Expansions in Patients With Myotonic Dystrophy Type 2 and Its Implication for Standard Diagnostics.2型强直性肌营养不良症患者重复序列扩增的更新结构及其对标准诊断的意义。
Neurol Genet. 2024 Dec 18;11(1):e200220. doi: 10.1212/NXG.0000000000200220. eCollection 2025 Feb.
3
Myotonic dystrophies: an update on clinical features, molecular mechanisms, management, and gene therapy.
强直性肌营养不良症:临床特征、分子机制、治疗及基因治疗的最新进展
Neurol Sci. 2025 Apr;46(4):1599-1616. doi: 10.1007/s10072-024-07826-9. Epub 2024 Dec 7.
4
Effectiveness and safety of mexiletine versus placebo in patients with myotonia: a systematic review and meta-analysis.美西律对比安慰剂治疗肌强直患者的有效性和安全性:系统评价和荟萃分析。
Neurol Sci. 2024 Aug;45(8):3989-4001. doi: 10.1007/s10072-024-07412-z. Epub 2024 Feb 26.
5
Parent-of-Origin Effect on the Age at Symptom Onset in Myotonic Dystrophy Type 2.2型强直性肌营养不良症中亲源效应与症状发作年龄的关系
Neurol Genet. 2023 Apr 24;9(3):e200073. doi: 10.1212/NXG.0000000000200073. eCollection 2023 Jun.
6
Targeting Myotonic Dystrophy Type 1 with Metformin.用二甲双胍靶向肌强直性营养不良 1 型。
Int J Mol Sci. 2022 Mar 7;23(5):2901. doi: 10.3390/ijms23052901.
7
The Role of RNA-Binding Proteins in Vertebrate Neural Crest and Craniofacial Development.RNA结合蛋白在脊椎动物神经嵴和颅面发育中的作用。
J Dev Biol. 2021 Aug 27;9(3):34. doi: 10.3390/jdb9030034.
8
Comparison of Shear Wave Elastography and Dynamometer Test in Muscle Tissue Characterization for Potential Medical and Sport Application.用于潜在医学和运动应用的肌肉组织特征化中剪切波弹性成像与测力计测试的比较。
Pathol Oncol Res. 2021 Jun 29;27:1609798. doi: 10.3389/pore.2021.1609798. eCollection 2021.
9
Myotonic dystrophy type 2: the 2020 update.肌强直性营养不良 2 型:2020 更新版。
Acta Myol. 2020 Dec 1;39(4):222-234. doi: 10.36185/2532-1900-026. eCollection 2020 Dec.
10
Recovery in the Myogenic Program of Congenital Myotonic Dystrophy Myoblasts after Excision of the Expanded (CTG) Repeat.先天性肌强直性营养不良成肌细胞中扩张(CTG)重复序列切除后的成肌细胞再生。
Int J Mol Sci. 2019 Nov 13;20(22):5685. doi: 10.3390/ijms20225685.